Teva and Amneal lose patent battle against Mallinckrodt

10-10-2016

Teva and Amneal lose patent battle against Mallinckrodt

Photo: Courtesy of Teva

Ireland-based biopharmaceutical company Mallinckrodt and Endo, a US healthcare business, have won a patent case against Amneal and Teva.


Teva, Amneal, Mallinckrodt, Endo, Opana, ANDA, FDA, patent

More on this story

Teva sells Paragard contraceptive for $1.1bn
13-09-2017

LSIPR